Acadia outlines $480M-$510M 2026 DAYBUE sales outlook as remlifanserin Phase II data nears Sep-Oct — See source for full details.
$ACAD
Price history, market instrument context, member research, and related headlines in one place.
ACAD key statistics
NasdaqGSUSD
52-week range
$18.3911%$30.96
Latest session $19.28–$19.88Acadia Pharmaceuticals Inc. (ACAD) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $19.71, up $0.46 (2.39%) from the previous close of $19.25. It has traded between $19.28 and $19.88 in the latest session. Over the past year it has ranged from $18.39 to $30.96, leaving it in the lower quarter of its 52-week range (11%). Reported volume for the session was 1.7M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $ACAD research…